TRENDING TOPICS
3055 articles found for "investing"
Robinhood traded $2.5 billion in prediction markets in its first three weeks and acquired a derivatives exchange, setting up a turf war in the $44 billion industry.
American Express shares plunged 8% on Feb 23, 2026, as the 15% tariff shock triggered the worst financial sector selloff of the year. AmEx's high-income cardholder base makes it Wall Street's real-time gauge of affluent spending.
Silver hit a record $121.78 per ounce in January 2026 after surging 147% in a year. With a sixth straight annual supply deficit and industrial demand from solar and EVs accelerating, the rally may have further to run.
Blue Owl's mandatory liquidation of its $1.6 billion BDC has trapped retail investors and triggered contagion across private credit, with KKR down 9% and Blackstone down 7%.
Software companies face a credit freeze as AI disruption fears send borrowing costs soaring and lenders walk away from the sector entirely.
IBM shares plunged 13% in the stock's worst single-day loss since 2000 after Anthropic announced Claude Code can modernize COBOL codebases in quarters instead of years.
Asian markets barely flinched at Trump's 15% global tariff while US futures plunged. South Korea's Kospi hit an all-time high, exposing who really pays for tariffs.
The New York Fed's recession probability model has climbed to 27% for September 2026 as the yield curve oscillates between normal and inverted in a pattern never seen before.
Goldman Sachs raised its Q4 2026 Brent forecast to $60 and WTI to $56 after OECD crude inventories fell faster than expected. The bank now sees Brent averaging $64 for the year, but warns Iranian sanctions relief could send prices $5 lower.
The S&P 500 has traded in its narrowest range by this point in February in six decades. Bollinger Bands are the tightest in five years. History says when markets coil this tight, the breakout that follows is large and fast.
ImmunityBio stock surged 24% after the European Commission approved ANKTIVA for bladder cancer and the company reported $113 million in product revenue, a 700% year-over-year increase. The drug is now authorized in 33 countries.
The Dow Jones Industrial Average plunged nearly 800 points Monday as two forces converged: growing fears that AI is displacing rather than enhancing corporate value, and the 15% global tariff taking effect at midnight.